Get the Stockscreener App
6.85
3.92%
-0.27
Pulmonx Corp stock is traded at $6.85, with a volume of 79,072.
It is down -3.92% in the last 24 hours and down -6.29% over the past month.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$7.12
Open:
$7.07
24h Volume:
79,072
Relative Volume:
0.31
Market Cap:
$275.23M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-4.2547
EPS:
-1.61
Net Cash Flow:
$-38.42M
1W Performance:
+1.04%
1M Performance:
-6.29%
6M Performance:
-30.34%
1Y Performance:
-31.04%
1-Day Range:
$6.815
$7.154
1-Week Range:
$6.05
$7.44
52-Week Range:
$5.46
$14.84
Pulmonx Corp Stock (LUNG) Company Profile
Name
Pulmonx Corp
Sector
Industry
Phone
650-364-0400
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-05-23 | Initiated | Craig Hallum | Buy |
| Feb-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Neutral |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-20 | Initiated | BofA Securities | Buy |
| Oct-26-20 | Initiated | Canaccord Genuity | Buy |
| Oct-26-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-26-20 | Initiated | Stifel | Buy |
| Oct-26-20 | Initiated | Wells Fargo | Equal Weight |
View All
Pulmonx Corp Stock (LUNG) Latest News
Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know - Yahoo Finance
Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results - Yahoo Finance
Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Pulmonx Corporation (NASDAQ:LUNG) Q3 2024 Earnings Call Transcript - Insider Monkey
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Earnings call: Pulmonx reports solid growth and strategic advances in Q3 - Investing.com UK
Pulmonx Corp (LUNG) Q3 2024 Earnings: Revenue Hits $20.4M, EPS a - GuruFocus.com
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... - Yahoo Finance UK
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... By GuruFocus - Investing.com Canada
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Pulmonx earnings beat by $0.81, revenue topped estimates - Investing.com
Pulmonx Reports Third Quarter 2024 Financial Results - Yahoo Finance
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
nVerses Capital LLC Buys Shares of 3,100 Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx (LUNG) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Pulmonx director sells $130,399 in common stock By Investing.com - Investing.com South Africa
Pulmonx director sells $130,399 in common stock - Investing.com India
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 - Yahoo Finance
Millennium Management LLC Lowers Stock Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Makes New Investment in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Squarepoint Ops LLC Acquires 104,432 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Point72 Asset Management L.P. Sells 2,474,183 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Takes $37,000 Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Phunware (NASDAQ:PHUN) Stock Price Up 4.2% - Defense World
PulteGroup Inc [PHM] Insider FOLLIARD THOMAS J sells 19,000 Shares – Latest News - Knox Daily
Urban Outfitters, Inc. (NASDAQ:URBN) Shares Sold by Shapiro Capital Management LLC - Defense World
Market Recap: Trupanion Inc (TRUP)’s Positive Momentum, Closing at 42.80 - The Dwinnex
Bank of New York Mellon Corp Purchases 17,740 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
PulteGroup, Inc. (NYSE:PHM) Shares Sold by MQS Management LLC - Defense World
Trupanion (NASDAQ:TRUP) Given New $45.00 Price Target at Northland Securities - Defense World
Texas Permanent School Fund Corp Has $1.08 Million Stake in Trupanion, Inc. (NASDAQ:TRUP) - Defense World
Intech Investment Management LLC Purchases 133,283 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World
Waterloo Capital L.P. Sells 223 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World
Trupanion (NASDAQ:TRUP) Shares Gap Up on Analyst Upgrade - MarketBeat
Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com Australia
Glendon E. French III Sells 20,000 Shares of Pulmonx Co. (NASDAQ:LUNG) Stock - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 - Yahoo Finance
Pulmonx executive sells over $30,000 in company stock - Investing.com India
Pulmonx corp general counsel sells over $38k in company stock - Investing.com
Pulmonx Co. (NASDAQ:LUNG) Insider Geoffrey Beran Rose Sells 4,586 Shares - MarketBeat
Pulmonx Corp (LUNG) looking to reclaim success with recent performance - SETE News
Pulmonx Co. (NASDAQ:LUNG) Sees Significant Decline in Short Interest - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Grows Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Buys 69,595 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference - Yahoo Finance
Investing in Pulmonx Corp (LUNG) Is Getting More Attractive - Knox Daily
Pulmonx Co. (NASDAQ:LUNG) CEO Steven S. Williamson Acquires 14,245 Shares of Stock - Defense World
Insider Buying: Pulmonx Co. (NASDAQ:LUNG) CEO Acquires 14,245 Shares of Stock - MarketBeat
Pulmonx CEO acquires $97k in company stock - Investing.com
Pulmonx Corp Stock (LUNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):